Squarepoint
NVNO

Squarepoint’s enVVeno Medical NVNO Stock Holding History

Squarepoint’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,184
Closed -$109K – 4879
2025
Q1 		$109K Sell
1,184
-184
-13% -$20.5K ﹤0.01% 4197
2024
Q4 		$145K Buy
+1,368
New +$153K ﹤0.01% 4583
2024
Q2 		– Sell
-640
Closed -$122K – 4471
2024
Q1 		$122K Buy
+640
New +$115K ﹤0.01% 3754
2023
Q3 		– Sell
-380
Closed -$40.9K – 4097
2023
Q2 		$40.9K Buy
+380
New +$49.3K ﹤0.01% 3456

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $58.1B AUM 27.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Squarepoint's NVNO Position: Q2 2025 in Review

Squarepoint sold out of enVVeno Medical (NVNO) in Q2 2025, closing a stake of 1,184 shares — an estimated $109K sold.

Squarepoint first reported a position in NVNO in Q2 2023 and held it in 4 quarters. The position peaked at $145K in Q4 2024. 37 funds tracked by Wall St. Rank hold NVNO as of Q2 2025.

  • Squarepoint reported no remaining enVVeno Medical position as of Q2 2025 after selling out during the quarter.
  • Squarepoint sold 1,184 enVVeno Medical shares in Q2 2025, an estimated $109K.
  • Squarepoint first reported a position in enVVeno Medical in Q2 2023 and held it in 4 quarters.
  • Squarepoint's enVVeno Medical position peaked at $145K in Q4 2024.
  • 37 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.